SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000875045-19-000006
Filing Date
2019-02-06
Accepted
2019-02-06 17:21:15
Documents
188
Period of Report
2018-12-31

Document Format Files

Seq Description Document Type Size
1 10-K biib-20181231x10k.htm 10-K 4462073
2 EXHIBIT 10.31 biib-20181231xex1031.htm EX-10.31 16202
3 EXHIBIT 21 biib-20181231xex21.htm EX-21 59445
4 EXHIBIT 23 biib-20181231xex23.htm EX-23 2571
5 EXHIBIT 31.1 biib-20181231xex311.htm EX-31.1 13955
6 EXHIBIT 31.2 biib-20181231xex312.htm EX-31.2 14298
7 EXHIBIT 32.1 biib-20181231xex321.htm EX-32.1 6574
14 acquirediprd.jpg GRAPHIC 19405
15 amortizationofintang.jpg GRAPHIC 19990
16 anticd20.jpg GRAPHIC 45497
17 avonex.jpg GRAPHIC 5670
18 benepalia04.jpg GRAPHIC 629417
19 biogenbubbles.jpg GRAPHIC 79712
20 biogenlogoa04.jpg GRAPHIC 62626
21 biosimilarrev.jpg GRAPHIC 29149
22 collabprofitshare.jpg GRAPHIC 18998
23 costofsales2018.jpg GRAPHIC 31949
24 fampyra.jpg GRAPHIC 2031
25 financialhighlights18.jpg GRAPHIC 36059
26 flixabi.jpg GRAPHIC 628388
27 fumaderm.jpg GRAPHIC 3140
28 gainlossonfvremeasurement.jpg GRAPHIC 18740
29 gazyva.jpg GRAPHIC 21759
30 imraldi.jpg GRAPHIC 629442
31 interferonrev.jpg GRAPHIC 36438
32 marketedproducts18.jpg GRAPHIC 84408
33 nci2018.jpg GRAPHIC 18832
34 ocrevus.jpg GRAPHIC 30240
35 otherincomeexpnet.jpg GRAPHIC 19200
36 performancegraph.jpg GRAPHIC 75082
37 plegridy.jpg GRAPHIC 5127
38 rdpercentofrev.jpg GRAPHIC 38455
39 researchanddev.jpg GRAPHIC 68930
40 reserves.jpg GRAPHIC 33122
41 restructuring2018.jpg GRAPHIC 18638
42 rituxan.jpg GRAPHIC 9985
43 rituxanhycelalogo300x87.jpg GRAPHIC 9120
44 royaltyandcorprev.jpg GRAPHIC 29701
45 sellinggeneralandadmin.jpg GRAPHIC 20754
46 spinrazalogonewa01.jpg GRAPHIC 72059
47 spinrazarev.jpg GRAPHIC 28566
48 taxexpense.jpg GRAPHIC 35587
49 tecfidera.jpg GRAPHIC 7384
50 tecfiderarev.jpg GRAPHIC 35548
51 teclitigation.jpg GRAPHIC 17899
52 tysabri.jpg GRAPHIC 6359
53 tysabrirev.jpg GRAPHIC 36720
54 zinbrytarev.jpg GRAPHIC 22455
  Complete submission text file 0000875045-19-000006.txt   27080903

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE DOCUMENT biib-20181231.xml EX-101.INS 5624077
9 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT biib-20181231.xsd EX-101.SCH 128511
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT biib-20181231_cal.xml EX-101.CAL 157367
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT biib-20181231_def.xml EX-101.DEF 793241
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT biib-20181231_lab.xml EX-101.LAB 1621427
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT biib-20181231_pre.xml EX-101.PRE 1138808
Mailing Address 225 BINNEY STREET CAMBRIDGE MA 02142
Business Address 225 BINNEY STREET CAMBRIDGE MA 02142 7814642000
BIOGEN INC. (Filer) CIK: 0000875045 (see all company filings)

IRS No.: 330112644 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-19311 | Film No.: 19572382
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences